# SOFGEN PHARMACEUTICALS LLC – FDA Inspection, Oct 18, 2017

Source: https://www.keypedia.com/records/fda_inspections/sofgen-pharmaceuticals-llc/b611ada5-c5b2-44f4-9bba-055823533b9c
Source feed: FDA_Inspections

> FDA inspection 1028977 of SOFGEN PHARMACEUTICALS LLC, October 18, 2017. Classification: Voluntary Action Indicated (VAI). 2 citations under 21 CFR part 211. Form 483 issued. 2 other FDA inspections on record for this company.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1028977
- Company Name: SOFGEN PHARMACEUTICALS LLC
- Inspection Date: 2017-10-18
- Classification: Voluntary Action Indicated (VAI)
- Classification Code: VAI
- Project Area: Drug Quality Assurance
- Product Type: Drugs
- Center: Human Drugs
- Office Name: Center for Drug Evaluation and Research
- Citation Count: 2

## Related Documents

- [FDA Inspection 1001551 - 2017-01-20](https://www.keypedia.com/records/fda_inspections/sofgen-pharmaceuticals-llc/bfd80be2-441e-40e2-90ca-9697437c8cb4)
- FDA Inspection 844635 - 2013-08-16

## Related Officers

- Issuing Officer
- [FDA Associated Person](https://www.keypedia.com/people/jennifer-l-huntington/c04e1c86-c7ec-4613-b3f7-a1f9ba2b2f2c)

Company: https://www.keypedia.com/companies/sofgen-pharmaceuticals-llc/03a9d5f6-f33a-4183-a9ba-b68bb9d7e0a7

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c